Optionsscheine finden
Nähere Informationen zum Handelssegment EASY EUWAX finden Sie hier.
► Tipp: Abonnieren Sie unsere Newsletter, um immer auf dem Laufenden bei aktuellen Wertpapierentwicklungen zu bleiben.
Ihre Auswahl:
902 Ergebnisse
| GW9AJR | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 40,515 % | - | - | - | 19.03.2027 | 0,100 | Goldman Sachs | ||
| GW9AK5 | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 36,241 % | - | - | - | 18.12.2026 | 0,100 | Goldman Sachs | ||
| GN025B | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 900,000 | 34,658 % | - | - | - | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GN025H | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | 38,807 % | - | - | - | 18.09.2026 | 0,100 | Goldman Sachs | ||
| GN04SB | Regeneron Pharmaceuticals Inc./OS/Call [800]/GOLDS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,568 % | 0,154 | -0,010 | 11,687 | 16.10.2026 | 0,010 | Goldman Sachs | ||
| JF83K3 | Regeneron Pharmaceuticals Inc./OS/Call [800]/JPM | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,623 % | 0,241 | -0,011 | 8,090 | 18.12.2026 | 0,010 | JP Morgan | ||
| JE1ZER | Regeneron Pharmaceuticals Inc./OS/Call [800]/JPMD | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,682 % | 0,374 | -0,011 | 5,541 | 19.03.2027 | 0,010 | JP Morgan | ||
| JY2U7U | Regeneron Pharmaceuticals Inc./OS/Call [800]/JPMD | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 36,021 % | 0,270 | -0,010 | 7,355 | 15.01.2027 | 0,010 | JP Morgan | ||
| MJ5417 |  | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 34,898 % | 0,282 | -0,012 | 8,034 | 18.12.2026 | 0,010 | Morgan Stanley | |
| MM02DX | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,884 % | 0,402 | -0,010 | 4,420 | 17.06.2027 | 0,010 | Morgan Stanley | |
| MM5GYY | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,718 % | 0,104 | -0,009 | 14,835 | 18.09.2026 | 0,010 | Morgan Stanley | |
| MN04N8 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 45,419 % | 0,488 | -0,010 | 3,170 | 17.12.2027 | 0,010 | Morgan Stanley | |
| MN1W0W | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | 57,620 % | - | - | - | 18.09.2026 | 0,100 | Morgan Stanley | |
| MN6F48 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,428 % | 0,348 | -0,011 | 5,370 | 19.03.2027 | 0,010 | Morgan Stanley | |
| MN8XDH | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | - | - | - | - | 19.03.2027 | 0,100 | Morgan Stanley | |
| MN8XDJ | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | - | - | - | - | 20.11.2026 | 0,100 | Morgan Stanley | |
| MN8XDK | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | - | - | - | - | 18.12.2026 | 0,100 | Morgan Stanley | |
| MR3CF5 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 50,201 % | 0,572 | -0,009 | 2,467 | 16.06.2028 | 0,010 | Morgan Stanley | |
| MR3SHM | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | - | - | - | - | 15.01.2027 | 0,100 | Morgan Stanley | |
| MR3SQ7 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/MS | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | 850,000 | - | - | - | - | 17.06.2027 | 0,100 | Morgan Stanley | |
| SX5KRA | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,717 % | 0,114 | -0,104 | 14,205 | 18.09.2026 | 0,100 | Société Générale | ||
| FA6MCY | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 34,035 % | 0,276 | -0,112 | 8,279 | 18.12.2026 | 0,100 | Société Générale | ||
| FD48N9 | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,449 % | 0,329 | -0,103 | 5,842 | 19.03.2027 | 0,100 | Société Générale | ||
| FD5DNA | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,462 % | 0,425 | -0,104 | 4,537 | 17.06.2027 | 0,100 | Société Générale | ||
| FD5DNC | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,714 % | 0,458 | -0,084 | 3,603 | 17.12.2027 | 0,100 | Société Générale | ||
| FE23H7 | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,027 % | 0,470 | -0,083 | 3,454 | 21.01.2028 | 0,100 | Société Générale | ||
| FE5AAG | Regeneron Pharmaceuticals Inc./OS/Call [800]/SOC | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,936 % | 0,534 | -0,079 | 2,933 | 16.06.2028 | 0,100 | Société Générale | ||
| VJ2MGN | | Regeneron Pharmaceuticals Inc./OS/Call [800]/VONT | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,891 % | 0,253 | -0,011 | 7,746 | 18.12.2026 | 0,010 | Vontobel | |
| VJ2MGX | | Regeneron Pharmaceuticals Inc./OS/Call [800]/VONT | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,189 % | 0,277 | -0,011 | 7,095 | 15.01.2027 | 0,010 | Vontobel | |
| VY3N3Y | | Regeneron Pharmaceuticals Inc./OS/Call [800]/VONT | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,733 % | 0,094 | -0,013 | 18,517 | 21.08.2026 | 0,010 | Vontobel | |
| VY5LQ4 | | Regeneron Pharmaceuticals Inc./OS/Call [800]/VONT | - | - | 800,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,609 % | 0,159 | -0,013 | 13,466 | 18.09.2026 | 0,010 | Vontobel | |
| GW0VHV | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,543 % | 0,381 | -0,010 | 4,635 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW0VHX | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 37,773 % | 0,318 | -0,010 | 5,868 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW0VJH | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,220 % | 0,269 | -0,011 | 6,988 | 15.01.2027 | 0,010 | Goldman Sachs | ||
| GW1J25 | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,351 % | 0,451 | -0,009 | 3,581 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K46 | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,826 % | 0,417 | -0,009 | 4,033 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K56 | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,355 % | 0,451 | -0,009 | 3,581 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K8Q | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,543 % | 0,381 | -0,010 | 4,635 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW1K9F | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,611 % | 0,463 | -0,008 | 3,437 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW3S6C | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,820 % | 0,479 | -0,008 | 3,255 | 17.03.2028 | 0,010 | Goldman Sachs | ||
| GW4QEZ | Regeneron Pharmaceuticals Inc./OS/Call [810]/GOLDS | - | - | 810,000 | call | Regeneron Pharmaceuticals Inc. | - | 41,806 % | 0,529 | -0,008 | 2,902 | 16.06.2028 | 0,010 | Goldman Sachs | ||
| GW02RB | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,948 % | 0,443 | -0,010 | 3,847 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW02RW | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,452 % | 0,370 | -0,010 | 4,697 | 17.06.2027 | 0,010 | Goldman Sachs | ||
| GW02Y8 | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 38,393 % | 0,307 | -0,010 | 5,852 | 19.03.2027 | 0,010 | Goldman Sachs | ||
| GW05ZY | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,725 % | 0,454 | -0,008 | 3,459 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1J0K | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,474 % | 0,442 | -0,008 | 3,605 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K44 | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,592 % | 0,412 | -0,009 | 3,991 | 17.09.2027 | 0,010 | Goldman Sachs | ||
| GW1K5A | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,255 % | 0,442 | -0,008 | 3,618 | 17.12.2027 | 0,010 | Goldman Sachs | ||
| GW1K5H | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 40,656 % | 0,454 | -0,008 | 3,463 | 21.01.2028 | 0,010 | Goldman Sachs | ||
| GW1K8S | Regeneron Pharmaceuticals Inc./OS/Call [820]/GOLDS | - | - | 820,000 | call | Regeneron Pharmaceuticals Inc. | - | 39,506 % | 0,370 | -0,010 | 4,693 | 17.06.2027 | 0,010 | Goldman Sachs |